ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer
Articolo
Data di Pubblicazione:
2020
Citazione:
ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer / Sonpavde, G., Necchi, A., Gupta, S., Steinberg, G.d., Gschwend, J.e., Van Der Heijden, M.s., Garzon, N., Ibrahim, M., Raybold, B., Liaw, D., Rutstein, M., Galsky, M.d.. - In: FUTURE ONCOLOGY. - ISSN 1479-6694. - 16:2(2020), pp. 4359-4368. [10.2217/fon-2019-0611]
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Sonpavde, G; Necchi, A; Gupta, S; Steinberg, Gd; Gschwend, Je; Van Der Heijden, Ms; Garzon, N; Ibrahim, M; Raybold, B; Liaw, D; Rutstein, M; Galsky, Md
Link alla scheda completa:
Pubblicato in: